Similar articles

• Detection of novel beta 2-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition.

  Ogawa H, Saito A, Oda O, Nakajima M, Chung TG. Ogawa H, et al. Clin Nephrol. 1988 Sep;30(3):158-63. Clin Nephrol. 1988. PMID: 3052955
• Beta-2-microglobulin-associated amyloidosis in chronic hemodialysis patients with carpal tunnel syndrome.

  Ullian ME, Hammond WS, Alfrey AC, Schultz A, Molitoris BA. Ullian ME, et al. Medicine (Baltimore). 1989 Mar;68(2):107-15. doi: 10.1097/00005792-198903000-00004. Medicine (Baltimore). 1989. PMID: 2646507
• Beta 2-microglobulin-related amyloidosis in patients receiving chronic hemodialysis.

  Gejyo F, Homma N, Maruyama H, Arakawa M. Gejyo F, et al. Contrib Nephrol. 1988;68:263-9. doi: 10.1159/000416524. Contrib Nephrol. 1988. PMID: 3069321 No abstract available.
• Dialysis amyloidosis: current disease concepts and new perspectives for its treatment.

  Gejyo F, Arakawa M. Gejyo F, et al. Contrib Nephrol. 1990;78:47-59; discussion 59-60. doi: 10.1159/000418269. Contrib Nephrol. 1990. PMID: 2225843 Review. No abstract available.
• [Dialysis-associated amyloidosis. Part 1: Biochemistry, clinical aspects, roentgen morphology].

  Rieden K, Ritz E, Post K, Barth HP, Haufe S, Wannenmacher M. Rieden K, et al. Bildgebung. 1993 Jun;60(2):63-7. Bildgebung. 1993. PMID: 8358214 Review. German.